Pfizer Inc. 2023-01-11 Health serious FDA
Health · FDA · Recall #FDA-D-0097-2023
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride… Recall
Issued January 11, 2023 · Pfizer Inc.
In January 2023, Pfizer Inc. recalled the Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of assurance of sterility: Bags have the potential to leak.
What you should do
- 1 Stop using Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Pfizer Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Pfizer Inc.
- Category
- Health
- Recall date
- January 11, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA.
- Recall number
- FDA-D-0097-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Pfizer Inc. has 13 recalls in our database, including 5 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.